Evidence map›Paper›PMID 40323318›Full record

ArticleThe Journal of experimental medicine2025

Neonatal microbiota colonization primes maturation of goblet cell-mediated protection in the pre-weaning colon.

Åsa Johansson, Mahadevan Venkita Subramani, Bahtiyar Yilmaz, Elisabeth E L Nyström, Elena Layunta, Liisa Arike, Felix Sommer, Philip Rosenstiel, Lars Vereecke, Louise Mannerås-Holm and 4 more

Erratum issuedAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Åsa Johansson *Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0009-0006-0489-4496
Mahadevan Venkita Subramani *Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0003-0442-919X
Bahtiyar YilmazDepartment for BioMedical Research, University of Bern, Bern, Switzerland.ORCID 0000-0003-1888-9226
Elisabeth E L NyströmDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-6970-7894
Elena LayuntaDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-5573-6144
Liisa ArikeDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-2184-0960
Felix SommerInstitute of Clinical & Molecular Biology, University of Kiel , Kiel, Germany.ORCID 0000-0002-6545-3487
Philip RosenstielInstitute of Clinical & Molecular Biology, University of Kiel , Kiel, Germany.ORCID 0000-0002-9692-8828
Lars VereeckeVIB-UGent Center for Inflammation Research , Ghent, Belgium.ORCID 0000-0002-1593-862X
Louise Mannerås-HolmWallenberg Laboratory, Institute of Medicine, University of Gothenburg , Gothenburg, Sweden.ORCID 0000-0001-8783-6107
Andy WullaertVIB-UGent Center for Inflammation Research , Ghent, Belgium.ORCID 0000-0001-5012-654X
Thaher PelaseyedDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-6434-3913
Malin E V JohanssonDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-4237-6677
George M H BirchenoughDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0003-2283-2353

Funding

Mucosal Immune Defense Mechanisms of the Urinary BladderU01AI095542 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, HULTGREN, SCOTT J. · 2011 to 2020
$9.8M
Cancerfonden 210301-JIACluster of Excellence Precision Medicine in Chronic InflammationDeutsche Forschungsgemeinschaft TP3IngaBritt and Arne Lundbergs Foundation LU2022-0069Knut and Alice Wallenberg FoundationNational Institute of Allergy and Infectious Diseases 5U01AI095542-10NIAID NIH HHS U01 AI095542Svenska Sällskapet för Medicinsk Forskning PD20-0168University of GothenburgVetenskåpsrådet 2018-02278
6 · The paper itself

Abstract

Regulated host-microbe interactions are a critical aspect of lifelong health. Colonic goblet cells protect from microorganisms via the generation of a mucus barrier structure. Bacteria-sensing sentinel goblet cells provide secondary protection by orchestrating mucus secretion when microbes breach the mucus barrier. Mucus deficiencies in germ-free mice implicate a role for the microbiota in programming barrier generation, but its natural ontogeny remains undefined. We now investigate the mucus barrier and sentinel goblet cell development in relation to postnatal colonization. Combined in vivo and ex vivo analyses demonstrate rapid and sequential microbiota-dependent development of these primary and secondary goblet cell protective functions, with dynamic changes in mucus processing dependent on innate immune signaling via MyD88 and development of functional sentinel goblet cells dependent on the NADPH/dual oxidase family member Duox2. Our findings identify new mechanisms of microbiota-goblet cell regulatory interaction and highlight the critical importance of the pre-weaning period for the normal development of protective systems that are key legislators of host-microbiota interaction.

Indexed as

ColonGastrointestinal MicrobiomeGoblet CellsMicrobiotaAnimalsAnimals, NewbornDual OxidasesImmunity, InnateIntestinal MucosaMiceMice, Inbred C57BLMice, KnockoutMucusMyeloid Differentiation Factor 88Signal TransductionWeaningDual OxidasesMyeloid Differentiation Factor 88

Identifiers

PMID40323318
PMCPMC12051479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.